Tag: Ulrik Zeuthen
-
Adalyon Appoints Ulrik Zeuthen as CEO to Drive Next Phase
Adalyon Names Ulrik Zeuthen as Chief Executive Officer to Lead Next Phase Espoo, Finland, Nov. 25, 2025 — Adalyon, a pioneer in AI-powered speech biomarker technology for clinical drug development, today announced the appointment of Ulrik Zeuthen as Chief Executive Officer. The move signals a strategic push to accelerate the company’s growth trajectory and advance…
-
Adalyon appoints Ulrik Zeuthen as CEO to drive next phase
Adalyon Announces CEO Appointment to Lead the Next Phase of Growth Adalyon, a Finnish biotech-tech firm focused on transforming clinical drug development through AI-powered speech biomarker technology, today announced the appointment of Ulrik Zeuthen as Chief Executive Officer. The leadership change signals the company’s commitment to accelerating product development, expanding strategic partnerships, and delivering on…